Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OHRP

OHR Pharmaceutical (OHRP) Stock Price, News & Analysis

OHR Pharmaceutical logo

About OHR Pharmaceutical Stock (NASDAQ:OHRP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$5.39
$9.07
52-Week Range
N/A
Volume
N/A
Average Volume
180,228 shs
Market Capitalization
$1.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

OHR Pharmaceutical, Inc. operates as a development stage pharmaceutical company. The company intends to merge with NeuBase Therapeutics, Inc. that focuses on advancing NeuBase's peptide-nucleic acid antisense oligonucleotide technology platform for the development of therapies to address severe and currently untreatable diseases caused by genetic mutations. OHR Pharmaceutical, Inc. is headquartered in New York, New York.

Receive OHRP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OHR Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

OHRP Stock News Headlines

Pharmaceutical Stocks
CYCC Cyclacel Pharmaceuticals, Inc.
Blackrock’s Sending THIS Crypto Higher on Purpose
While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.
OHR Pharmaceutical (OHRP) is now in Oversold Territory
See More Headlines

OHRP Stock Analysis - Frequently Asked Questions

OHR Pharmaceutical Inc (NASDAQ:OHRP) released its earnings results on Tuesday, August, 14th. The biotechnology company reported ($0.20) EPS for the quarter.

OHR Pharmaceutical's stock reverse split on the morning of Monday, February 4th 2019. The 1-20 reverse split was announced on Wednesday, January 23rd 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, February 1st 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that OHR Pharmaceutical investors own include Actinium Pharmaceuticals (ATNM), TherapeuticsMD (TXMD), IVERIC bio (OPHT), Cytori Therapeutics (CYTX), Novavax (NVAX), Immunomedics (IMMU) and Synergy Pharmaceuticals (SGYP).

Company Calendar

Last Earnings
8/14/2018
Today
5/05/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:OHRP
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-13,230,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$3.86 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$1.08 million
Optionable
Not Optionable
Beta
0.84
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:OHRP) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners